EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access

Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in Uganda

John Kasibante iD, Eesha Irfanullah, Abduljewad Wele, Elizabeth C Okafor, Kenneth Ssebambulidde iD, Samuel Okurut, Enock Kagimu iD, Jane Gakuru iD, Morris K Rutakingirwa, Timothy Mugabi, Edwin Nuwagira, Samuel Jjunju und 9 weitere

Medical Mycology · 2024

DOI: 10.1093/mmy/myae101 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Medical Mycology, 2024. Verfasst von John Kasibante und 20 weiteren Autor:innen. Beteiligte Einrichtung: Infectious Diseases Institute, College of Health Sciences, Makerere University, P.O. Box 22418, Kampala, Uganda. Hauptthemen laut MEDLINE: Meningitis, Cryptococcal, HIV Infections, Cerebrospinal Fluid Proteins. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINDS NIH HHS, FIC NIH HHS, Grand Challenges Canada.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebrospinal fluid (CSF) protein levels exhibit high variability in HIV-associated cryptococcal meningitis; however, its clinical implications remain unclear. We analyzed data from 890 adults with HIV-associated cryptococcal meningitis randomized into two clinical trials in Uganda between 2015 and 2021. CSF protein was grouped into < 100 mg/dl (72%, n = 641) and ≥ 100 mg/dl (28%, n = 249). We described baseline clinical variables and 18-week mortality by CSF protein groups. Those with CSF protein ≥ 100 mg/dl were more likely to present with Glasgow coma scale score < 15 (P < .01), self-reported seizures at baseline (P = .02), higher CD4 T-cell count (P < .001), and higher CSF white blood cells (P < .001). Moreover, those with a baseline CSF protein ≥ 100 mg/dl also had a lower baseline CSF fungal burden (P < .001) and a higher percentage of sterile CSF cultures at day 14 (P = .02). Individuals with CSF protein ≥ 100 mg/dl demonstrated a more pronounced immune response consisting of upregulation of immune effector molecules, pro-inflammatory cytokines, T-helper cell type 1 and 17 cytokines, and immune-exhaustion marker (P < .05). 18-week mortality risk in individuals with a CSF protein < 100 mg/dl was 34% higher (unadjusted Hazard Ratio 1.34; 95% Confidence Interval, 1.05–1.70; P = .02) than those with CSF protein ≥ 100 mg/dl. In HIV-associated cryptococcal meningitis, individuals with baseline CSF protein ≥ 100 mg/dl more frequently presented with neurological symptoms, higher CSF inflammatory cytokines, reduced fungal burden, and lower mortality risk. The findings underscore the prognostic significance of baseline CSF protein levels in predicting disease severity and mortality risk in cryptococcal meningitis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Meningitis, CryptococcalHIV InfectionsCerebrospinal Fluid ProteinsHumansUgandaAdultMaleFemaleProspective StudiesAIDS-Related Opportunistic InfectionsCD4 Lymphocyte CountCytokinesMiddle AgedClinical Relevance

Stichwörter der Autor:innen

CSF cytokinesCSF proteinHIVbiomarkerscryptococcal meningitis

Substanzen

Cerebrospinal Fluid ProteinsCytokines

Autor:innen und Institutionen

  • Infectious Diseases Institute, College of Health Sciences, Makerere University, P.O. Box 22418, Kampala, Uganda.
  • Department of Medicine, Division of Infectious Diseases & International Medicine, University of Minnesota, Minneapolis, MN, USA.
  • Department of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda.

ORCID-Profile: John Kasibante, Kenneth Ssebambulidde, Enock Kagimu, Jane Gakuru, David B Meya, Mahsa Abassi

Förderung

  • NINDS NIH HHS
  • FIC NIH HHS
  • Grand Challenges Canada
  • United Kingdom Medical Research Council/Department for International International Developement/Wellcome Trust Global Clinical Trials
  • NIAID NIH HHS
  • European and Developing Countries Clinical Trials Partnership
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Neurologic Diseases and Stroke

Zitieren

APA

Kasibante, J., Irfanullah, E., Wele, A., Okafor, E. C., Ssebambulidde, K., Okurut, S., Kagimu, E., Gakuru, J., Rutakingirwa, M. K., Mugabi, T., Nuwagira, E., Jjunju, S., Mpoza, E., Tugume, L., Nsangi, L., Musibire, A. K., Muzoora, C., Rhein, J., Meya, D. B., …, & Abassi, M. (2024). Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in Uganda. Medical Mycology. https://doi.org/10.1093/mmy/myae101

Vancouver

Kasibante J, Irfanullah E, Wele A, Okafor EC, Ssebambulidde K, Okurut S, et al. Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in Uganda. Medical Mycology. 2024. doi:10.1093/mmy/myae101

BibTeX
@article{Kasibante2024,
  author = {Kasibante, John and Irfanullah, Eesha and Wele, Abduljewad and Okafor, Elizabeth C and Ssebambulidde, Kenneth and Okurut, Samuel and Kagimu, Enock and Gakuru, Jane and Rutakingirwa, Morris K and Mugabi, Timothy and Nuwagira, Edwin and Jjunju, Samuel and Mpoza, Edward and Tugume, Lillian and Nsangi, Laura and Musibire, Abdu K and Muzoora, Conrad and Rhein, Joshua and Meya, David B and Boulware, David R and Abassi, Mahsa},
  title = {Clinical importance of cerebrospinal fluid protein levels in HIV-associated cryptococcal meningitis: Insights from a prospective cohort study in Uganda},
  journal = {Medical Mycology},
  year = {2024},
  doi = {10.1093/mmy/myae101}
}
Kostenlos starten →